Medixine Ltd Revenue and Competitors

Espoo,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Medixine Ltd's estimated annual revenue is currently $3.7M per year.(i)
  • Medixine Ltd's estimated revenue per employee is $112,000

Employee Data

  • Medixine Ltd has 33 Employees.(i)
  • Medixine Ltd grew their employee count by 32% last year.

Medixine Ltd's People

NameTitleEmail/Phone
1
VP EngineeringReveal Email/Phone
2
AssistantReveal Email/Phone
3
AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.9M4114%N/AN/A
Add Company

What Is Medixine Ltd?

Medixine offers a comprehensive communication, monitoring and collaboration tools for all parties involved in the care process. One platform solution for all needs in Connected Care: *Remote patient monitoring *Screening *Case management *Video appointments *Secure chat *Secure messaging *Forms and questionnaires Our solutions enable smooths collaboration between health care providers, patients and family members. We provide tools for connecting different data sources and optimizing care processes. With our help, our partners and customers can enhance the quality of care and achieve cost savings. The Medixine Suite product is medical device certified & ISO-9001 and ISO-13485 certified and protected by 15 patents and patent applications.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$3.7M

Revenue (est)

32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medixine Ltd News

2022-03-22 - How Finnish innovations are helping reshape the post-pandemic world

Medixine also offers a communication, monitoring, and collaboration platform for healthcare workers. It seeks to lighten the load for...

2022-02-22 - Valentine's Day Offerings from Chicago Restaurants

Wood's menu has options for two such as their limited time Dry ... two pours of the Medixin Monk “Expresso” cocktail (a housemade Fernet...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M3338%N/A
#2
$8.4M3436%N/A
#3
$7.1M36-8%N/A
#4
N/A36157%N/A
#5
$4.3M376%N/A